Global Liver Cirrhosis Therapeutics Market Insights and Forecast to 2031

Report ID: 1450867 | Published Date: Oct 2024 | No. of Page: 114 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Liver Cirrhosis Therapeutics Product Introduction
    1.2 Market by Type
        1.2.1 Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral
        1.2.3 Injection
    1.3 Market by Application
        1.3.1 Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Liver Cirrhosis Therapeutics Sales Estimates and Forecasts 2017-2028
    2.2 Global Liver Cirrhosis Therapeutics Revenue Estimates and Forecasts 2017-2028
    2.3 Global Liver Cirrhosis Therapeutics Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Liver Cirrhosis Therapeutics Sales by Region
        2.4.1 Global Liver Cirrhosis Therapeutics Sales by Region (2017-2022)
        2.4.2 Global Sales Liver Cirrhosis Therapeutics by Region (2023-2028)
    2.5 Global Liver Cirrhosis Therapeutics Revenue by Region
        2.5.1 Global Liver Cirrhosis Therapeutics Revenue by Region (2017-2022)
        2.5.2 Global Liver Cirrhosis Therapeutics Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Liver Cirrhosis Therapeutics Sales by Manufacturers
        3.1.1 Global Top Liver Cirrhosis Therapeutics Manufacturers by Sales (2017-2022)
        3.1.2 Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liver Cirrhosis Therapeutics in 2021
    3.2 Global Liver Cirrhosis Therapeutics Revenue by Manufacturers
        3.2.1 Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (2017-2022)
        3.2.2 Global Liver Cirrhosis Therapeutics Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Liver Cirrhosis Therapeutics Revenue in 2021
    3.3 Global Liver Cirrhosis Therapeutics Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Liver Cirrhosis Therapeutics Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Liver Cirrhosis Therapeutics Sales by Type
        4.1.1 Global Liver Cirrhosis Therapeutics Historical Sales by Type (2017-2022)
        4.1.2 Global Liver Cirrhosis Therapeutics Forecasted Sales by Type (2023-2028)
        4.1.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    4.2 Global Liver Cirrhosis Therapeutics Revenue by Type
        4.2.1 Global Liver Cirrhosis Therapeutics Historical Revenue by Type (2017-2022)
        4.2.2 Global Liver Cirrhosis Therapeutics Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    4.3 Global Liver Cirrhosis Therapeutics Price by Type
        4.3.1 Global Liver Cirrhosis Therapeutics Price by Type (2017-2022)
        4.3.2 Global Liver Cirrhosis Therapeutics Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Liver Cirrhosis Therapeutics Sales by Application
        5.1.1 Global Liver Cirrhosis Therapeutics Historical Sales by Application (2017-2022)
        5.1.2 Global Liver Cirrhosis Therapeutics Forecasted Sales by Application (2023-2028)
        5.1.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    5.2 Global Liver Cirrhosis Therapeutics Revenue by Application
        5.2.1 Global Liver Cirrhosis Therapeutics Historical Revenue by Application (2017-2022)
        5.2.2 Global Liver Cirrhosis Therapeutics Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    5.3 Global Liver Cirrhosis Therapeutics Price by Application
        5.3.1 Global Liver Cirrhosis Therapeutics Price by Application (2017-2022)
        5.3.2 Global Liver Cirrhosis Therapeutics Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Liver Cirrhosis Therapeutics Market Size by Type
        6.1.1 North America Liver Cirrhosis Therapeutics Sales by Type (2017-2028)
        6.1.2 North America Liver Cirrhosis Therapeutics Revenue by Type (2017-2028)
    6.2 North America Liver Cirrhosis Therapeutics Market Size by Application
        6.2.1 North America Liver Cirrhosis Therapeutics Sales by Application (2017-2028)
        6.2.2 North America Liver Cirrhosis Therapeutics Revenue by Application (2017-2028)
    6.3 North America Liver Cirrhosis Therapeutics Market Size by Country
        6.3.1 North America Liver Cirrhosis Therapeutics Sales by Country (2017-2028)
        6.3.2 North America Liver Cirrhosis Therapeutics Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Liver Cirrhosis Therapeutics Market Size by Type
        7.1.1 Europe Liver Cirrhosis Therapeutics Sales by Type (2017-2028)
        7.1.2 Europe Liver Cirrhosis Therapeutics Revenue by Type (2017-2028)
    7.2 Europe Liver Cirrhosis Therapeutics Market Size by Application
        7.2.1 Europe Liver Cirrhosis Therapeutics Sales by Application (2017-2028)
        7.2.2 Europe Liver Cirrhosis Therapeutics Revenue by Application (2017-2028)
    7.3 Europe Liver Cirrhosis Therapeutics Market Size by Country
        7.3.1 Europe Liver Cirrhosis Therapeutics Sales by Country (2017-2028)
        7.3.2 Europe Liver Cirrhosis Therapeutics Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Liver Cirrhosis Therapeutics Market Size by Type
        8.1.1 Asia Pacific Liver Cirrhosis Therapeutics Sales by Type (2017-2028)
        8.1.2 Asia Pacific Liver Cirrhosis Therapeutics Revenue by Type (2017-2028)
    8.2 Asia Pacific Liver Cirrhosis Therapeutics Market Size by Application
        8.2.1 Asia Pacific Liver Cirrhosis Therapeutics Sales by Application (2017-2028)
        8.2.2 Asia Pacific Liver Cirrhosis Therapeutics Revenue by Application (2017-2028)
    8.3 Asia Pacific Liver Cirrhosis Therapeutics Market Size by Region
        8.3.1 Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2017-2028)
        8.3.2 Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Liver Cirrhosis Therapeutics Market Size by Type
        9.1.1 Latin America Liver Cirrhosis Therapeutics Sales by Type (2017-2028)
        9.1.2 Latin America Liver Cirrhosis Therapeutics Revenue by Type (2017-2028)
    9.2 Latin America Liver Cirrhosis Therapeutics Market Size by Application
        9.2.1 Latin America Liver Cirrhosis Therapeutics Sales by Application (2017-2028)
        9.2.2 Latin America Liver Cirrhosis Therapeutics Revenue by Application (2017-2028)
    9.3 Latin America Liver Cirrhosis Therapeutics Market Size by Country
        9.3.1 Latin America Liver Cirrhosis Therapeutics Sales by Country (2017-2028)
        9.3.2 Latin America Liver Cirrhosis Therapeutics Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Liver Cirrhosis Therapeutics Market Size by Type
        10.1.1 Middle East and Africa Liver Cirrhosis Therapeutics Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Type (2017-2028)
    10.2 Middle East and Africa Liver Cirrhosis Therapeutics Market Size by Application
        10.2.1 Middle East and Africa Liver Cirrhosis Therapeutics Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Application (2017-2028)
    10.3 Middle East and Africa Liver Cirrhosis Therapeutics Market Size by Country
        10.3.1 Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Gilead Sciences
        11.1.1 Gilead Sciences Corporation Information
        11.1.2 Gilead Sciences Overview
        11.1.3 Gilead Sciences Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Gilead Sciences Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Gilead Sciences Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Johnson and Johnson
        11.3.1 Johnson and Johnson Corporation Information
        11.3.2 Johnson and Johnson Overview
        11.3.3 Johnson and Johnson Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Johnson and Johnson Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson and Johnson Recent Developments
    11.4 Merck
        11.4.1 Merck Corporation Information
        11.4.2 Merck Overview
        11.4.3 Merck Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Merck Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck Recent Developments
    11.5 Roche
        11.5.1 Roche Corporation Information
        11.5.2 Roche Overview
        11.5.3 Roche Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Roche Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Roche Recent Developments
    11.6 Bristol-Myers Squibb
        11.6.1 Bristol-Myers Squibb Corporation Information
        11.6.2 Bristol-Myers Squibb Overview
        11.6.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Bristol-Myers Squibb Recent Developments
    11.7 Conatus Pharmaceuticals
        11.7.1 Conatus Pharmaceuticals Corporation Information
        11.7.2 Conatus Pharmaceuticals Overview
        11.7.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Conatus Pharmaceuticals Recent Developments
    11.8 Gwo Xi Stem Cell Applied Technology
        11.8.1 Gwo Xi Stem Cell Applied Technology Corporation Information
        11.8.2 Gwo Xi Stem Cell Applied Technology Overview
        11.8.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Gwo Xi Stem Cell Applied Technology Recent Developments
    11.9 Instituto Grifols
        11.9.1 Instituto Grifols Corporation Information
        11.9.2 Instituto Grifols Overview
        11.9.3 Instituto Grifols Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Instituto Grifols Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Instituto Grifols Recent Developments
    11.10 Intercept Pharmaceuticals
        11.10.1 Intercept Pharmaceuticals Corporation Information
        11.10.2 Intercept Pharmaceuticals Overview
        11.10.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Intercept Pharmaceuticals Recent Developments
    11.11 NGM Biopharmaceuticals
        11.11.1 NGM Biopharmaceuticals Corporation Information
        11.11.2 NGM Biopharmaceuticals Overview
        11.11.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 NGM Biopharmaceuticals Recent Developments
    11.12 Norgine
        11.12.1 Norgine Corporation Information
        11.12.2 Norgine Overview
        11.12.3 Norgine Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Norgine Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Norgine Recent Developments
    11.13 Pharmicell
        11.13.1 Pharmicell Corporation Information
        11.13.2 Pharmicell Overview
        11.13.3 Pharmicell Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Pharmicell Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Pharmicell Recent Developments
    11.14 Salix Pharmaceuticals
        11.14.1 Salix Pharmaceuticals Corporation Information
        11.14.2 Salix Pharmaceuticals Overview
        11.14.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Salix Pharmaceuticals Recent Developments
    11.15 Stempeutics Research
        11.15.1 Stempeutics Research Corporation Information
        11.15.2 Stempeutics Research Overview
        11.15.3 Stempeutics Research Liver Cirrhosis Therapeutics Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Stempeutics Research Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Stempeutics Research Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Liver Cirrhosis Therapeutics Industry Chain Analysis
    12.2 Liver Cirrhosis Therapeutics Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Liver Cirrhosis Therapeutics Production Mode & Process
    12.4 Liver Cirrhosis Therapeutics Sales and Marketing
        12.4.1 Liver Cirrhosis Therapeutics Sales Channels
        12.4.2 Liver Cirrhosis Therapeutics Distributors
    12.5 Liver Cirrhosis Therapeutics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Liver Cirrhosis Therapeutics Industry Trends
    13.2 Liver Cirrhosis Therapeutics Market Drivers
    13.3 Liver Cirrhosis Therapeutics Market Challenges
    13.4 Liver Cirrhosis Therapeutics Market Restraints
14 Key Findings in The Global Liver Cirrhosis Therapeutics Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
List of Tables
    Table 1. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Liver Cirrhosis Therapeutics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Liver Cirrhosis Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 7. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2017-2022)
    Table 8. Global Liver Cirrhosis Therapeutics Sales by Region (2023-2028) & (K Units)
    Table 9. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2023-2028)
    Table 10. Global Liver Cirrhosis Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2017-2022)
    Table 12. Global Liver Cirrhosis Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2023-2028)
    Table 14. Global Liver Cirrhosis Therapeutics Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Liver Cirrhosis Therapeutics Sales Share by Manufacturers (2017-2022)
    Table 16. Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Liver Cirrhosis Therapeutics Revenue Share by Manufacturers (2017-2022)
    Table 18. Liver Cirrhosis Therapeutics Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Liver Cirrhosis Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Liver Cirrhosis Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cirrhosis Therapeutics as of 2021)
    Table 21. Liver Cirrhosis Therapeutics Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Liver Cirrhosis Therapeutics Product Offered
    Table 23. Date of Manufacturers Enter into Liver Cirrhosis Therapeutics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 26. Global Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 27. Global Liver Cirrhosis Therapeutics Sales Share by Type (2017-2022)
    Table 28. Global Liver Cirrhosis Therapeutics Sales Share by Type (2023-2028)
    Table 29. Global Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Liver Cirrhosis Therapeutics Revenue Share by Type (2017-2022)
    Table 32. Global Liver Cirrhosis Therapeutics Revenue Share by Type (2023-2028)
    Table 33. Liver Cirrhosis Therapeutics Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Liver Cirrhosis Therapeutics Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 36. Global Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 37. Global Liver Cirrhosis Therapeutics Sales Share by Application (2017-2022)
    Table 38. Global Liver Cirrhosis Therapeutics Sales Share by Application (2023-2028)
    Table 39. Global Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Liver Cirrhosis Therapeutics Revenue Share by Application (2017-2022)
    Table 42. Global Liver Cirrhosis Therapeutics Revenue Share by Application (2023-2028)
    Table 43. Liver Cirrhosis Therapeutics Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Liver Cirrhosis Therapeutics Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 46. North America Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 47. North America Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 50. North America Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 51. North America Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Liver Cirrhosis Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 54. North America Liver Cirrhosis Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 55. North America Liver Cirrhosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Liver Cirrhosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Liver Cirrhosis Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Liver Cirrhosis Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Liver Cirrhosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Liver Cirrhosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Liver Cirrhosis Therapeutics Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Liver Cirrhosis Therapeutics Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Liver Cirrhosis Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Liver Cirrhosis Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Liver Cirrhosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Liver Cirrhosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Liver Cirrhosis Therapeutics Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Liver Cirrhosis Therapeutics Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Gilead Sciences Corporation Information
    Table 106. Gilead Sciences Description and Major Businesses
    Table 107. Gilead Sciences Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Gilead Sciences Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Gilead Sciences Recent Developments
    Table 110. GlaxoSmithKline Corporation Information
    Table 111. GlaxoSmithKline Description and Major Businesses
    Table 112. GlaxoSmithKline Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. GlaxoSmithKline Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GlaxoSmithKline Recent Developments
    Table 115. Johnson and Johnson Corporation Information
    Table 116. Johnson and Johnson Description and Major Businesses
    Table 117. Johnson and Johnson Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Johnson and Johnson Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Johnson and Johnson Recent Developments
    Table 120. Merck Corporation Information
    Table 121. Merck Description and Major Businesses
    Table 122. Merck Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Merck Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Merck Recent Developments
    Table 125. Roche Corporation Information
    Table 126. Roche Description and Major Businesses
    Table 127. Roche Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Roche Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Roche Recent Developments
    Table 130. Bristol-Myers Squibb Corporation Information
    Table 131. Bristol-Myers Squibb Description and Major Businesses
    Table 132. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Bristol-Myers Squibb Recent Developments
    Table 135. Conatus Pharmaceuticals Corporation Information
    Table 136. Conatus Pharmaceuticals Description and Major Businesses
    Table 137. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Conatus Pharmaceuticals Recent Developments
    Table 140. Gwo Xi Stem Cell Applied Technology Corporation Information
    Table 141. Gwo Xi Stem Cell Applied Technology Description and Major Businesses
    Table 142. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Gwo Xi Stem Cell Applied Technology Recent Developments
    Table 145. Instituto Grifols Corporation Information
    Table 146. Instituto Grifols Description and Major Businesses
    Table 147. Instituto Grifols Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Instituto Grifols Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Instituto Grifols Recent Developments
    Table 150. Intercept Pharmaceuticals Corporation Information
    Table 151. Intercept Pharmaceuticals Description and Major Businesses
    Table 152. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Intercept Pharmaceuticals Recent Developments
    Table 155. NGM Biopharmaceuticals Corporation Information
    Table 156. NGM Biopharmaceuticals Description and Major Businesses
    Table 157. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. NGM Biopharmaceuticals Recent Developments
    Table 160. Norgine Corporation Information
    Table 161. Norgine Description and Major Businesses
    Table 162. Norgine Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Norgine Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Norgine Recent Developments
    Table 165. Pharmicell Corporation Information
    Table 166. Pharmicell Description and Major Businesses
    Table 167. Pharmicell Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 168. Pharmicell Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Pharmicell Recent Developments
    Table 170. Salix Pharmaceuticals Corporation Information
    Table 171. Salix Pharmaceuticals Description and Major Businesses
    Table 172. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 173. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Salix Pharmaceuticals Recent Developments
    Table 175. Stempeutics Research Corporation Information
    Table 176. Stempeutics Research Description and Major Businesses
    Table 177. Stempeutics Research Liver Cirrhosis Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 178. Stempeutics Research Liver Cirrhosis Therapeutics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Stempeutics Research Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Liver Cirrhosis Therapeutics Distributors List
    Table 183. Liver Cirrhosis Therapeutics Customers List
    Table 184. Liver Cirrhosis Therapeutics Market Trends
    Table 185. Liver Cirrhosis Therapeutics Market Drivers
    Table 186. Liver Cirrhosis Therapeutics Market Challenges
    Table 187. Liver Cirrhosis Therapeutics Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Liver Cirrhosis Therapeutics Product Picture
    Figure 3. Global Liver Cirrhosis Therapeutics Market Share by Type in 2021 & 2028
    Figure 3. Oral Product Picture
    Figure 4. Injection Product Picture
    Figure 5. Global Liver Cirrhosis Therapeutics Market Share by Application in 2021 & 2028
    Figure 6. Hospital
    Figure 7. Clinic
    Figure 8. Others
    Figure 9. Liver Cirrhosis Therapeutics Report Years Considered
    Figure 10. Global Liver Cirrhosis Therapeutics Sales 2017-2028 (K Units)
    Figure 11. Global Liver Cirrhosis Therapeutics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Liver Cirrhosis Therapeutics Revenue 2017-2028 (US$ Million)
    Figure 13. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2017-2022)
    Figure 15. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2023-2028)
    Figure 16. North America Liver Cirrhosis Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Liver Cirrhosis Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Liver Cirrhosis Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Liver Cirrhosis Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Liver Cirrhosis Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Liver Cirrhosis Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Liver Cirrhosis Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Liver Cirrhosis Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Liver Cirrhosis Therapeutics Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Liver Cirrhosis Therapeutics Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Liver Cirrhosis Therapeutics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Liver Cirrhosis Therapeutics in the World: Market Share by Liver Cirrhosis Therapeutics Revenue in 2021
    Figure 28. Global Liver Cirrhosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 30. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 31. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 32. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 33. North America Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 34. North America Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 35. North America Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 36. North America Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 37. North America Liver Cirrhosis Therapeutics Sales Share by Country (2017-2028)
    Figure 38. North America Liver Cirrhosis Therapeutics Revenue Share by Country (2017-2028)
    Figure 39. U.S. Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 42. Europe Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 44. Europe Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Liver Cirrhosis Therapeutics Sales Share by Country (2017-2028)
    Figure 46. Europe Liver Cirrhosis Therapeutics Revenue Share by Country (2017-2028)
    Figure 47. Germany Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 48. France Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Liver Cirrhosis Therapeutics Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Liver Cirrhosis Therapeutics Revenue Share by Region (2017-2028)
    Figure 58. China Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 61. India Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Liver Cirrhosis Therapeutics Sales Share by Country (2017-2028)
    Figure 73. Latin America Liver Cirrhosis Therapeutics Revenue Share by Country (2017-2028)
    Figure 74. Mexico Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Liver Cirrhosis Therapeutics Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Liver Cirrhosis Therapeutics Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Liver Cirrhosis Therapeutics Revenue Share by Country (2017-2028)
    Figure 83. Turkey Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Liver Cirrhosis Therapeutics Revenue (2017-2028) & (US$ Million)
    Figure 86. Liver Cirrhosis Therapeutics Value Chain
    Figure 87. Liver Cirrhosis Therapeutics Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gilead Sciences
GlaxoSmithKline
Johnson and Johnson
Merck
Roche
Bristol-Myers Squibb
Conatus Pharmaceuticals
Gwo Xi Stem Cell Applied Technology
Instituto Grifols
Intercept Pharmaceuticals
NGM Biopharmaceuticals
Norgine
Pharmicell
Salix Pharmaceuticals
Stempeutics Research
Frequently Asked Questions
Liver Cirrhosis Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Liver Cirrhosis Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Liver Cirrhosis Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Dental Services

Dental Services market is segmented by players, region (country), by Type and by Application. Pla ... Read More